Axicabtagene is a CAR-T therapy where a person's T-cells are engineered to target CD19, which is found on the surface of certain cancerous cells.
Axicabtagene is a CAR-T therapy where a person's T-cells are engineered to target CD19. Target CD19 is found on the surface of certain cancerous cells.